ReleaseWire

Late last month Silicon Valley legend, Roger Sippl, launched Connection Cloud via his new start-up, Elastic Intelligence.

DesparServizi Italy: Consumer Profile is the result of Canadean’s extensive online consumer survey DesparServizi in Italy, presenting uniquely detailed data on DesparServizi’s end-consumers. It provides retailer profiles for both Main and Occasional consumers (determined by the share of their goods coming from this retailer) covering over 25 individual consumer groups, and retailer share at product category level.

Sisa Italy: Consumer Profile is the result of Canadean’s extensive online consumer survey Sisa in Italy, presenting uniquely detailed data on Sisa’s end-consumers. It provides retailer profiles for both Main and Occasional consumers (determined by the share of their goods coming from this retailer) covering over 25 individual consumer groups, and retailer share at product category level.

“UK Foodservice Survey 2012-2013: Evolution of POS and Self Service in Consumer Satisfaction” is a new report by Canadean that analyzes if the role and impact of new POS and self service technology in the UK foodservice industry are set to change in 2012-2013. This report provides the reader with a definitive analysis of the new techniques and technologies in the foodservice industry, and identifies how organizations plan to leverage them in future. Furthermore, this report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by sector and revenue.

Publix US: Consumer Profile is the result of Canadean’s extensive online consumer survey Publix in the US, presenting uniquely detailed data on Publix’s end-consumers. It provides retailer profiles for both Main and Occasional consumers (determined by the share of their goods coming from this retailer) covering over 25 individual consumer groups, and retailer share at product category level.

“Medical Diagnostic & Therapeutic Ultrasound Devices Market (2012 - 2017) [By Technology, Applications & Products, (2D, 3D & 4D, Doppler, High Intensity Focused Ultrasound (HIFU), Extracorporeal Shockwave Lithotripsy (ESWL), Cart/Trolley, Compact/Portable & Hand-held] Global Trends & Competitive Analysis”

Recently published data suggests that people seeking counselling for common mental health problems are more likely to recover if they pay to go privately. Statistics published by The British CBT & Counselling Service show an 85% recovery rate amongst their patients compared to an average recovery rate of less than 50% amongst patients receiving similar treatment in the NHS for conditions such as Depression, Anxiety, Eating Disorders, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Grief and Relationship Problems. The reason for this significant difference in success rates is likely to be funding which is impacting once again on the NHS’s ability to provide what is the nation needs.

An investigation for former Progress Energy, Inc. (NYSE:PGN) investors, who now hold shares of Duke Energy (NYSE: DUK), over potential breaches of fiduciary duties was announced and former NYSE:PGN investors, who now hold NYSE:DUK shares, should contact the Shareholders Foundation.

A lawsuit was filed by an investor in NASDAQ:MODL shares in effort to block the proposed takeover of MModal Inc and other NASDAQ:MODL stockholders should contact the Shareholders Foundation.

A lawsuit was filed for certain investors in PolyMedix, Inc. (OTC:PYMX) over alleged securities laws violations by PolyMedix, Inc. Deadline: August 31, 2012. PYMX investors should contact the Shareholders Foundation, Inc.

A lawsuit was filed for certain investors in NYSE:CNC shares over alleged securities laws violations by Centene Corp. Deadline: August 28, 2012. NYSE:CNC investors should contact the Shareholders Foundation.

A lawsuit was filed for investors in NASDAQ:AMLN shares to stop the proposed takeover of Amylin Pharmaceuticals, Inc. and other NASDAQ:AMLN stockholders should contact the Shareholders Foundation.

An investigation on behalf of investors of Brightpoint, Inc. (NASDAQ:CELL) in connection with the takeover was announced and NASDAQ:CELL stockholders should contact the Shareholders Foundation.

An investigation on behalf of investors of Lincare Holdings Inc. (NASDAQ:LNCR) in connection with the takeover was announced and NASDAQ:LNCR stockholders should contact the Shareholders Foundation.

An investors in NYSE:LPR filed a lawsuit Lone Pine Resources Inc and over alleged securities laws violations and investors, who purchased their NYSE:LPR in the May 2011 IPO or shortly after may 26, 2011 should contact the Shareholders Foundation.

An investigation on behalf of investors in NYSE:KRC shares over potential breaches of fiduciary duties by certain directors of Kilroy Realty Corp was announced and current long-term NYSE:KRC stockholders should contact the Shareholders Foundation.

An investigation on behalf of current long term investors in ModusLink Global Solutions, Inc. (NASDAQ:MLNK) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ:MLNK stockholders should contact the Shareholders Foundation.

A lawsuit for U.S. based investors who purchased or sold Euribor-related financial instruments over alleged Euribor Rate Fixing was filed and those investors should contact the Shareholders Foundation.

Over the past 6 years, three major events have impacted the autism spectrum disorders market. In 2006, Risperdal became the first drug to receive approval from the US FDA for the symptomatic treatment of irritability in children and adolescents with ASDs. Later, in 2009, the FDA approved Abilify for the same indication. In 2008, generic risperidone launched following Risperdal's US patent expiry.

The colon cancer pipeline has grown as pharmaceutical companies are attracted by the high incidence and success of other developers. Cytotoxics will remain an integral part of treatment, but with key brands expected to come off patent over the forecast period and the approval of new therapies, treatment of this growing market is set to evolve.

Canadean's, "Fortified Wine in Asia-Pacific to 2016: Market Guide" provides in-depth detail on the trends and drivers of the Fortified Wine market in Asia-Pacific. The quantitative data in the report (historic and forecast market values) analyses the dynamics in the Asia-Pacific countries, providing marketers with the essential information to understand their own and their competitors' position in this market and the information to accurately identify where to compete in the future.

Costco US: Consumer Profile is the result of Canadean's extensive online consumer survey Costco in the US, presenting uniquely detailed data on Costco's end-consumers. It provides retailer profiles for both Main and Occasional consumers (determined by the share of their goods coming from this retailer) covering over 25 individual consumer groups, and retailer share at product category level.

"First Oil plc" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into "First Oil plc". The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company's business structure, operations and products, and provides an analysis of its key revenue lines.

"Underground Gas Storage in North America - Market Analysis, Competitive Landscape and Forecasts to 2016", is the latest report from GlobalData, the industry analysis specialists, which analyzes the underground gas storage industry in the North American region. The report provides information about North America's underground gas storage market, with forecasts until 2016, and gives information on the key gas storage sites and companies in the region. The report also provides details of the key drivers and issues in the gas storage industry. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Metastatic Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.